Co-occurring Depression and Suicidal Ideation in Opioid Use Disorder: Prevalence and Response During Treatment With Buprenorphine-Naloxone and Injection Naltrexone.
Na PJ, Scodes J, Fishman M, Rotrosen J, Nunes EV. Co-occurring Depression and Suicidal Ideation in Opioid Use Disorder: Prevalence and Response During Treatment With Buprenorphine-Naloxone and Injection Naltrexone. The Journal Of Clinical Psychiatry 2022, 83 PMID: 35452194, DOI: 10.4088/jcp.21m14140.Peer-Reviewed Original ResearchConceptsOpioid use disorderWeeks of treatmentBuprenorphine-naloxoneCo-occurring depressionSevere depressionWeek 4Mild depressionUse disordersSuicidal ideationMedication treatment groupExtended-release naltrexoneInitiation of treatmentOpioid use outcomesPrevalence of depressionRisk of relapseDeaths of despairInjection naltrexoneXR-NTXOpioid useDepression treatmentFrequent historyTreatment groupsPatientsLogistic regressionAnxiety disorders“Lives of despair” at risk for “deaths of despair”: tracking an under-recognized, vulnerable population
Na PJ, Stefanovics EA, Rhee TG, Rosenheck RA. “Lives of despair” at risk for “deaths of despair”: tracking an under-recognized, vulnerable population. Social Psychiatry And Psychiatric Epidemiology 2022, 57: 1123-1134. PMID: 35028698, PMCID: PMC8757395, DOI: 10.1007/s00127-022-02218-w.Peer-Reviewed Original ResearchConceptsSubstance use disordersLifetime substance use disorderDeaths of despairSuicide attemptsUS adultsMental health service utilizationMental health care servicesQuality mental health careHealth service utilizationRelated Conditions Wave IIIMental health treatmentMental health careNational Epidemiologic SurveyQuality of lifeMore psychosocial adversityHealth care servicesCharacteristics of adultsMultivariable analysisService utilizationPsychiatric disordersUse disordersEpidemiologic SurveyWave IIIHealth treatmentAdverse experiences